Reason for exclusion of all 6514 screened articles. by Solima Sabeel (9545738)

Fig 1 - by Maris Lohmöller (16985922)

Alterations of egg transparency by drugs containing inhibitors of physiological functions. by Takumi T. Shito (11849291)

Participant Recruitment Flowchart. by Sandra M. Ragheb (12975445)

Characteristics of Participants (n = 65). by Sandra M. Ragheb (12975445)

Patient Engagement Panel Key Messages. by Sandra M. Ragheb (12975445)

Screenshots of the mHealth Platform. by Sandra M. Ragheb (12975445)

Hh signaling activation by dnPKA-GFP decreases p53 target <i>cyclinG1</i> expression and suppresses apoptosis in <i>shh</i>^−/− mutant embryos. by Sergey V. Prykhozhij (239274)

“…All of EGFP-injected embryos had “low” expression of <i>patched1</i>, 25,3 +/− 1,15% (Mean +/− standard deviation) of them had “high” expression of <i>cyclinG1</i> and 24,7 +/− 1,53% had “high” apoptosis levels. dnPKA-GFP mRNA injection led to “high” expression of <i>patched1</i> in 87,7 +/− 3,8% of embryos and decreased expression of <i>cyclinG1</i> and apoptosis levels: “high” proportions are 6 +/− 2% and 5,8 +/− 2,4%, respectively. …”

Methodological items for non-randomized studies (MINORS). by Solima Sabeel (9545738)

Jadad Score of randomized controlled trials. by Solima Sabeel (9545738)

Association Between App Feasibility and Quality of Life and 30-Day Hospital Readmission. by Sandra M. Ragheb (12975445)

Version 2 of the Cochrane risk-of-bias tool for randomized controlled trials. by Solima Sabeel (9545738)

Analysis of randomized controlled trials stratified based on treatment duration. by Solima Sabeel (9545738)

PRISMA flow diagram of the systematic literature search process. by Solima Sabeel (9545738)

Excluded skewed studies. by Solima Sabeel (9545738)

Fig 2 - by Natália de Souza Duarte (18264611)

Summary of randomized controlled trials. by Solima Sabeel (9545738)

Summary of non-randomized studies. by Solima Sabeel (9545738)

Uniform growth case with overdamped dynamics: Tissue area and cell area using a viscous solver, under different viscosity factors. by George Courcoubetis (6277931)

Post-Discharge MHealth Participant Satisfaction Responses by Age Category. Categorical variables expressed as n (%). Percentages include participants who Agreed or Strongly Agreed... by Sandra M. Ragheb (12975445)